Research
Title : | Non-infringing routes for the synthesis of FDA approved life saving drugs |
Area of research : | Chemical Sciences |
Focus area : | Synthesis of FDA approved life-saving drugs |
Principal Investigator : | Dr Debaraj Mukherjee, Scientist, CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu |
Timeline Start Year : | 2020 |
Timeline End Year : | 2023 |
Contact info : | dmukherjee@iiim_ac_in |
Details
Executive Summary : | Objective: Novel route for C/N glycosylation and optimization of key reactions; Short, economic, and novel route for the synthesis of Delamanid; Translate the optimized synthetic methodologies to develop the synthesis of Dapagliflozin and Sofosbuvir; Novel route for the synthesis of Delamanid and optimization of Key reactions; Filing of the patents and publication of research and technology transfer. |
Organizations involved
Implementing Agency : | CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu Funding Agency :Council of Scientific and Industrial Research (CSIR), Government of India | Source (more info) :https://csirprojects.anusandhan.net/ | |